Tapewire

Nasdaq · USD

IRWD

IRONWOOD PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
5213
SEC CIK
0001446847
Parsed reports
478

Last 12 months

Inside the activity.

0 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202601
Feb 2026012
Mar 202602
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 15, 2022 Filed Aug 17, 2022 16:05 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 994 $11.77 $11,699.38
Disclosure

SEC source: 0001209191-22-046223 · doc4.xml · nonDerivative · entry 1

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,736

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on September 4, 2018.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 20:05 UTC
Silver RonaldPrincipal Accounting Officer
SaleClass A Common Stock 2,014 $11.77 $23,704.78
Disclosure

SEC source: 0001209191-22-046225 · doc4.xml · nonDerivative · entry 1

Silver Ronald · CIK 0001873731 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,151

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: The reporting person acquired 2,092 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2022.

Read SEC document
August 11, 2022 Filed Aug 15, 2022 20:17 UTC SaleClass A Common Stock 70,000 $11.78 $824,600.00
Disclosure

SEC source: 0001209191-22-045808 · doc4.xml · nonDerivative · entry 1

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 521,758

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.64 to $11.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 09, 2022 Filed Aug 10, 2022 16:06 UTC
Rickard JasonSVP, Chief Operating Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 18,041 $0.00 Strike: $11.65 $0.00
Disclosure

SEC source: 0001209191-22-045179 · doc4.xml · derivative · entry 5

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 18,041 shares

Expires 2023-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
August 09, 2022 Filed Aug 10, 2022 16:06 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 18,041 $11.75 $211,981.75
Disclosure

SEC source: 0001209191-22-045179 · doc4.xml · nonDerivative · entry 4

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376,730

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.74 to $11.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 09, 2022 Filed Aug 10, 2022 16:06 UTC
Rickard JasonSVP, Chief Operating Officer
Exercise / conversionClass A Common Stock 18,041 $11.65 $210,177.65
Disclosure

SEC source: 0001209191-22-045179 · doc4.xml · nonDerivative · entry 3

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 394,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 16:06 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 2,236 $11.56 $25,848.16
Disclosure

SEC source: 0001209191-22-045179 · doc4.xml · nonDerivative · entry 2

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376,730

Read SEC document
August 08, 2022 Filed Aug 10, 2022 16:06 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 27,200 $11.64 $316,608.00
Disclosure

SEC source: 0001209191-22-045179 · doc4.xml · nonDerivative · entry 1

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 378,966

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.63 to $11.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · balance_after: The reporting person acquired 2,092 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2022.

Read SEC document
August 01, 2022 Filed Aug 3, 2022 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 23,229 $11.35 $263,649.15
Disclosure

SEC source: 0001209191-22-044162 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 757,785

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.30 to $11.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: The reporting person acquired 2,092 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2022.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 19,959 $11.58 $231,125.22
Disclosure

SEC source: 0001209191-22-040558 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 778,922

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
June 15, 2022 Filed Jun 18, 2022 00:11 UTC
DENNER ALEXANDER JDirector · 10% owner
GrantClass A Common Stock 1,222 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-038192 · doc4.xml · nonDerivative · entry 1

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,367

F1 · kind: Issued pursuant to the Director Compensation Policy, effective May 2019.

Read SEC document
June 14, 2022 Filed Jun 16, 2022 20:05 UTC SaleClass A Common Stock 7,610 $11.65 $88,656.50
Disclosure

SEC source: 0001209191-22-037400 · doc4.xml · nonDerivative · entry 1

Kessler Marla L · CIK 0001772124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,148

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
June 07, 2022 Filed Jun 9, 2022 21:04 UTC Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 190,383 $0.00 Strike: $11.65 $0.00
Disclosure

SEC source: 0001209191-22-035443 · doc4.xml · derivative · entry 3

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 190,383 shares

Expires 2023-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option, vested as to 1.25% on each monthly anniversary of the vesting commencement date for the first 36 months, and as to 4.5833% of the award on each monthly anniversary thereafter, is presently exercisable in full.

Read SEC document
June 07, 2022 Filed Jun 9, 2022 21:04 UTC SaleClass A Common Stock 190,383 $12.01 $2,286,499.83
Disclosure

SEC source: 0001209191-22-035443 · doc4.xml · nonDerivative · entry 2

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 591,758

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 07, 2022 Filed Jun 9, 2022 21:04 UTC Exercise / conversionClass A Common Stock 190,383 $11.65 $2,217,961.95
Disclosure

SEC source: 0001209191-22-035443 · doc4.xml · nonDerivative · entry 1

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 782,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:05 UTC GrantClass A Common Stock 21,571 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-033965 · doc4.xml · nonDerivative · entry 1

Dreyfus Andrew · CIK 0001670893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,639

F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

F2 · balance_after: The total amount of shares beneficially owned has been adjusted to correct prior immaterial computational errors.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:06 UTC
McHugh JulieDirector
GrantClass A Common Stock 21,571 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-033973 · doc4.xml · nonDerivative · entry 1

McHugh Julie · CIK 0001487179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,944

F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:06 UTC GrantClass A Common Stock 21,571 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-033983 · doc4.xml · nonDerivative · entry 1

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 591,758

F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:05 UTC GrantClass A Common Stock 21,571 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-033968 · doc4.xml · nonDerivative · entry 1

Kessler Marla L · CIK 0001772124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,758

F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:06 UTC
Shepard JayDirector
GrantClass A Common Stock 21,571 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-033982 · doc4.xml · nonDerivative · entry 1

Shepard Jay · CIK 0001587788 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,894

F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:06 UTC
Duane Jon RDirector
GrantClass A Common Stock 21,571 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-033980 · doc4.xml · nonDerivative · entry 1

Duane Jon R · CIK 0001772129 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,758

F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:05 UTC
DENNER ALEXANDER JDirector · 10% owner
GrantClass A Common Stock 21,571 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-033974 · doc4.xml · nonDerivative · entry 1

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,145

F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:05 UTC GrantClass A Common Stock 21,571 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-033969 · doc4.xml · nonDerivative · entry 1

Moukheibir Catherine · CIK 0001772130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,350

F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
May 23, 2022 Filed May 25, 2022 16:05 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
SaleClass A Common Stock 7,453 $11.50 $85,709.50
Disclosure

SEC source: 0001209191-22-031842 · doc4.xml · nonDerivative · entry 2

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,245

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 50% of the reporting person's restricted stock units granted on March 26, 2021.

Read SEC document
May 23, 2022 Filed May 25, 2022 16:05 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
SaleClass A Common Stock 3,130 $11.50 $35,995.00
Disclosure

SEC source: 0001209191-22-031842 · doc4.xml · nonDerivative · entry 1

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,698

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on April 24, 2020.

Read SEC document
May 23, 2022 Filed May 25, 2022 16:05 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 12,760 $11.50 $146,740.00
Disclosure

SEC source: 0001209191-22-031841 · doc4.xml · nonDerivative · entry 2

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 404,074

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 50% of the reporting person's restricted stock units granted on March 26, 2021.

Read SEC document
May 23, 2022 Filed May 25, 2022 16:05 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 777 $11.50 $8,935.50
Disclosure

SEC source: 0001209191-22-031841 · doc4.xml · nonDerivative · entry 1

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,834

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on May 1, 2019.

Read SEC document
May 23, 2022 Filed May 25, 2022 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 11,848 $11.50 $136,252.00
Disclosure

SEC source: 0001209191-22-031844 · doc4.xml · nonDerivative · entry 3

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 798,881

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on June 7, 2021.

Read SEC document
May 23, 2022 Filed May 25, 2022 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 21,873 $11.50 $251,539.50
Disclosure

SEC source: 0001209191-22-031844 · doc4.xml · nonDerivative · entry 2

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 810,729

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 50% of the reporting person's restricted stock units granted on March 26, 2021.

Read SEC document
May 23, 2022 Filed May 25, 2022 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 2,587 $11.50 $29,750.50
Disclosure

SEC source: 0001209191-22-031844 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 832,602

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on May 1, 2019.

Read SEC document
May 23, 2022 Filed May 25, 2022 20:05 UTC
Silver RonaldPrincipal Accounting Officer
SaleClass A Common Stock 120 $11.50 $1,380.00
Disclosure

SEC source: 0001209191-22-031843 · doc4.xml · nonDerivative · entry 1

Silver Ronald · CIK 0001873731 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,073

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on April 1, 2019.

Read SEC document
March 24, 2022 Filed Mar 25, 2022 20:07 UTC
Silver RonaldPrincipal Accounting Officer
SaleClass A Common Stock 3,031 $12.75 $38,645.25
Disclosure

SEC source: 0001209191-22-021097 · doc4.xml · nonDerivative · entry 1

Silver Ronald · CIK 0001873731 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,193

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
March 15, 2022 Filed Mar 17, 2022 20:06 UTC
DENNER ALEXANDER JDirector · 10% owner
GrantClass A Common Stock 1,152 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-019537 · doc4.xml · nonDerivative · entry 1

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,574

F1 · kind: Issued pursuant to the Director Compensation Policy, effective May 2019.

Read SEC document
March 15, 2022 Filed Mar 17, 2022 20:05 UTC GrantClass A Common Stock 1,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-019522 · doc4.xml · nonDerivative · entry 1

Moukheibir Catherine · CIK 0001772130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,779

F1 · kind: Issued pursuant to the Director Compensation Policy, effective May 2019.

Read SEC document
March 14, 2022 Filed Mar 16, 2022 20:05 UTC
McHugh JulieDirector
SaleClass A Common Stock 20,000 $11.67 $233,400.00
Disclosure

SEC source: 0001209191-22-019205 · doc4.xml · nonDerivative · entry 1

McHugh Julie · CIK 0001487179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,373

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.55 to $11.77, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
GrantClass A Common Stock 248,869 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-017840 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 835,189

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 16:05 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
GrantClass A Common Stock 81,448 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-016184 · doc4.xml · nonDerivative · entry 1

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,828

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 16:05 UTC
John MinardoChief Legal Officer
GrantClass A Common Stock 67,873 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-016185 · doc4.xml · nonDerivative · entry 1

John Minardo · CIK 0001875067 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,765

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 16:05 UTC
Rickard JasonSVP, Chief Operating Officer
GrantClass A Common Stock 90,498 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-016187 · doc4.xml · nonDerivative · entry 1

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 417,611

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 21:05 UTC
Silver RonaldPrincipal Accounting Officer
GrantClass A Common Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-016188 · doc4.xml · nonDerivative · entry 2

Silver Ronald · CIK 0001873731 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,224

F2 · kind: The restricted stock unit award, granted as a promotion award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 21:05 UTC
Silver RonaldPrincipal Accounting Officer
GrantClass A Common Stock 17,013 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-016188 · doc4.xml · nonDerivative · entry 1

Silver Ronald · CIK 0001873731 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,224

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 16:01 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
SaleClass A Common Stock 4,364 $10.77 $47,000.28
Disclosure

SEC source: 0001209191-22-014652 · doc4.xml · nonDerivative · entry 5

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,380

F5 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 22, 2021.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 16:01 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
SaleClass A Common Stock 3,804 $10.77 $40,969.08
Disclosure

SEC source: 0001209191-22-014652 · doc4.xml · nonDerivative · entry 4

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,744

F4 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting of the reporting person's performance-based restricted stock units granted on April 24, 2020

Read SEC document
February 28, 2022 Filed Mar 2, 2022 16:01 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
SaleClass A Common Stock 5,161 $10.77 $55,583.97
Disclosure

SEC source: 0001209191-22-014652 · doc4.xml · nonDerivative · entry 3

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,548

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting of the reporting person's performance-based restricted stock units granted on February 27, 2020.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 16:01 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
SaleClass A Common Stock 2,911 $10.77 $31,351.47
Disclosure

SEC source: 0001209191-22-014652 · doc4.xml · nonDerivative · entry 2

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,709

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 16:01 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
SaleClass A Common Stock 1,367 $10.77 $14,722.59
Disclosure

SEC source: 0001209191-22-014652 · doc4.xml · nonDerivative · entry 1

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,620

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 1, 2019.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 16:00 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 6,820 $10.77 $73,451.40
Disclosure

SEC source: 0001209191-22-014650 · doc4.xml · nonDerivative · entry 5

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 327,113

F5 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 22, 2021.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 16:00 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 11,057 $10.77 $119,083.89
Disclosure

SEC source: 0001209191-22-014650 · doc4.xml · nonDerivative · entry 4

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,933

F4 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting of the reporting person's performance-based restricted stock units granted on February 27, 2020.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 16:00 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 6,022 $10.77 $64,856.94
Disclosure

SEC source: 0001209191-22-014650 · doc4.xml · nonDerivative · entry 3

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,990

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 16:00 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 3,150 $10.77 $33,925.50
Disclosure

SEC source: 0001209191-22-014650 · doc4.xml · nonDerivative · entry 2

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,012

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 29, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.